Company Overview of DNIB Unwind, Inc.
On October 11, 2016, DNIB Unwind, Inc. went out of business as per its Chapter 11 liquidation filing under bankruptcy. DNIB Unwind, Inc. engaged in the development of novel targeted therapeutics primarily for the treatment of cancer in the United States and Russia. The company was formerly known as BIND Therapeutics, Inc. and changed its name to DNIB Unwind, Inc. in August 2016. DNIB Unwind, Inc. was founded in 2006 and is based in Cambridge, Massachusetts.
325 Vassar Street
Cambridge, MA 02139
Founded in 2006
Key Executives for DNIB Unwind, Inc.
DNIB Unwind, Inc. does not have any Key Executives recorded.
DNIB Unwind, Inc. Key Developments
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
July 1, 2016
|BIND Therapeutics, Inc., Substantially All of the Assets|
May 1, 2016
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact DNIB Unwind, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.